Stealth BioTherapeutics Announces Departure of Chief Financial Officer

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization...

Related Keywords

Boston ,Massachusetts ,United States ,Adam Bero ,Robert Weiskopf ,Reenie Mccarthy ,Exchange Commission ,Prnewswire Stealth Biotherapeutics Corp Nasdaq ,Stealth Biotherapeutics Inc ,Morningside Venturei Investments Ltd ,J Wood Capital Advisors ,Morningside Venture ,Capital Advisors ,Private Securities Litigation Reform Act ,Annual Report ,Biotechnology ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Personnel Announcements ,